600568.SH
ST中珠
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 2.16
−2.26%Margins
Gross margin
16.4%
EBITDA margin
-11.6%
EBIT margin
-23.0%
Net margin
-21.4%
FCF margin
-2.2%
-7.2%
Return on equity
-6.0%
Return on assets
-7.7%
Return on invested capital
0.28x
Asset turnover
CNY 21.7M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026